1. Home
  2. CRVL vs TARS Comparison

CRVL vs TARS Comparison

Compare CRVL & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CorVel Corp.

CRVL

CorVel Corp.

N/A

Current Price

$71.70

Market Cap

2.8B

Sector

Finance

ML Signal

N/A

Logo Tarsus Pharmaceuticals Inc.

TARS

Tarsus Pharmaceuticals Inc.

N/A

Current Price

$77.06

Market Cap

2.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CRVL
TARS
Founded
1987
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Insurers
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.7B
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
CRVL
TARS
Price
$71.70
$77.06
Analyst Decision
Buy
Analyst Count
0
6
Target Price
N/A
$89.00
AVG Volume (30 Days)
147.1K
653.8K
Earning Date
05-21-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
16.94
48.21
EPS
0.63
N/A
Revenue
$958,527,000.00
$451,360,000.00
Revenue This Year
N/A
$56.43
Revenue Next Year
N/A
$30.19
P/E Ratio
$114.02
N/A
Revenue Growth
7.03
146.71
52 Week Low
$44.83
$53.89
52 Week High
$80.79
$91.53

Technical Indicators

Market Signals
Indicator
CRVL
TARS
Relative Strength Index (RSI) 64.93 52.19
Support Level $65.62 $60.95
Resistance Level N/A $79.10
Average True Range (ATR) 1.87 3.70
MACD 0.06 -1.01
Stochastic Oscillator 95.01 17.02

Price Performance

Historical Comparison
CRVL
TARS

About CRVL CorVel Corp.

CorVel Corp applies technology including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. It partners with employers, third-party administrators, insurance companies, and government agencies in managing worker's compensation and health, auto, and liability services. The company's solutions combine integrated technologies with a human touch providing services that include claims management, bill review, preferred provider networks, utilization management, case management, pharmacy services, directed care, and medicare services.

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis. TP-04 for the potential treatment of ocular rosacea and TP-05 for potential Lyme disease prophylaxis and community malaria reduction.

Share on Social Networks: